Lifeward Q2 revenue skyrockets 16% to $6.6 million

• Lifeward reported Q2 2026 revenue of $6.62 million, up 16% year-over-year, while adjusted loss was $1.46 per share.
• Adjusted EPS beat the Zacks estimate by 2.01%, although revenue missed the consensus estimate by 10.74%.
• Lifeward ended June with $9.4 million in cash and said it expects revenue momentum to continue during the second half of 2026.

Lifeward (NASDAQ:LFWD) reported Q2 2026 revenue of $6.62 million, up 16% year-over-year, while adjusted loss was $1.46 per share.

The adjusted loss beat the Zacks consensus estimate of $1.49 by 2.01%, while revenue missed its consensus estimate by 10.74%.

GAAP net loss was $11.5 million, gross margin fell to 41% from 44%, and unrestricted cash reached $9.4 million.

Lifeward said it expects revenue momentum to continue in H2.

Elsewhere, ReWalk Personal exoskeleton sales increased 13% to $2.5 million, while AlterG products and services revenue rose 25% to $4.1 million.

Lifeward also secured up to $11.2 million of strategic financing in July and launched an Ottobock Care pilot to expand ReWalk access.